Milly Marston1,2,3,4,5,6, Renaud Becquet1,2,3,4,5,6, Basia Żaba1,2,3,4,5,6, Lawrence H. Moulton1,2,3,4,5,6, Glenda Gray1,2,3,4,5,6, Hoosen Coovadia1,2,3,4,5,6, Max Essex1,2,3,4,5,6, Didier K. Ekouévi1,2,3,4,5,6, Debra Jackson1,2,3,4,5,6, Anna Coutsoudis1,2,3,4,5,6, Charles Kilewo1,2,3,4,5,6, Valériane Leroy1,2,3,4,5,6, Stefan Z. Wiktor1,2,3,4,5,6, Ruth Nduati1,2,3,4,5,6, Philippe Msellati1,2,3,4,5,6, François Dabis1,2,3,4,5,6, Marie‐Louise Newell1,2,3,4,5,6, Peter D. Ghys1,2,3,4,5,6
1Botswana-Harvard AIDS Institute and Harvard School of Health AIDS Initiative, 8Ditrame Plus cohort, Côte d'Ivoire, 9Good Start cohort, South Africa
2Global AIDS Program, Centers for Disease Control and Prevention, Atlanta, USA, 14Nairobi trial, Kenya, 15ANRSb trial, Côte d'Ivoire & Burkina Faso, UMR 145 IRD/Universite de Montpellier 1, montpeillier, France, 16Africa Centre for Health and Population Studies, University of KwaZulu-Natal, Somkhele, South Africa, 17Centre for Paediatric Epidemiology and Biostatistics, Institute of Child Health, University College London, London, UK, and 18UNAIDS, Joint United Nations Programme on HIV/AIDS, Geneva, Switzerland
3Johns Hopkins Bloomberg School of Public Health, 5Petra trial, Tanzania, South Africa and Uganda
4London School of Hygiene and Tropical Medicine, London, UK, 2INSERM, unité 897, Centre de recherche "Epidémiologie et Biostatistique", Bordeaux, France, 3Institut de Santé Publique Epidémiologie Développement (ISPED), Université Victor Segalen Bordeaux 2, Bordeaux, France, 4ZVITAMBO trial, Zimbabwe
5Perinatal HIV Research Unit, University of Witwatersrand, 6VTS cohort, South Africa, University of KwaZulu-Natal, University of Witwatersrand, South Africa, 7Mashi trial, Botswana
6University of the Western Cape, South Africa, 10Vitamin A trial, South Africa, 11Mitra Plus cohort, Tanzania, 12ANRSa trial, Côte d'Ivoire & Burkina Faso, 13Retro-Ci trial, Côte d'Ivoire
